Recombinetics (United States)
Recombinetics is a St. Paul, Minnesota-based bio-engineering company. The company was founded in 2008, and has since raised $31 million from private investors. Mark Platt is the CEO. In November 2024, Recombinetics filed for Chapter 11 bankruptcy protection. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Recombinetics (United States), United States, covering academic research published from 2005 to 2024. Read More.
Open Access Percentage
69%
Total
Publications
182
Total Open
Publications
126
Total
Citations
7K
Open Access
Percentage
69%
Total
Publications
182
Total Open
Publications
126
Total
Citations
7K
Breakdown
Publisher Open
17%
Both
43%
Other Platform Open
7%
Closed
33%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 56%
57
Hybrid 16%
16
No Guarantees 28%
29
Other Platform Open
Domain 91%
80
Institution 32%
28
Other Internet 16%
14
Preprint 2%
2
Public 2%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 79 |
DOI | Other Internet | 14 |
Università Cattolica del Sacro Cuore - PubliCatt | Institution | 9 |
Europe PMC | Domain | 8 |
São Paulo State University - UNESP Institutional Repository | Institution | 7 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 6 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 4 |
Ecole Polytechnique Fédérale de Lausanne - Infoscience | Institution | 4 |
Alma Mater Studiorum Università di Bologna - Archivio istituzionale della ricerca | Institution | 4 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 3 |